Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome.
paper
Cited
Public
Unavailable
- Authors
- Siarey, R J; Carlson, E J; Epstein, C J; Balbo, A; Rapoport, S I; Galdzicki, Z
- Year
- 1999
- Journal
- Neuropharmacology
- PMID
- 10608287
- DOI
- 10.1016/s0028-3908(99)00083-0
Long-term potentiation (LTP) and depression (LTD) were investigated in hippocampus of a genetic model of Down syndrome, the segmental trisomy (Ts65Dn) mouse. Field excitatory postsynaptic potentials were recorded from hippocampal slices and LTP and LTD evoked sequentially. LTP decreased whereas LTD increased significantly in Ts65Dn compared with control hippocampus.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Profiling hippocampal neuronal populations reveals unique gene expression mosaics reflective of connectivity-based degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. | Alldred MJ et al. | β | 2025 | β |
| Consequences of trisomy 21 for brain development in Down syndrome. | Russo ML et al. | β | 2024 | β |
| Direct modulation of G protein-gated inwardly rectifying potassium (GIRK) channels. | Nguyen H et al. | β | 2024 | β |
| The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses. | Lockshin ER et al. | β | 2024 | β |
| Trisomy 21 impairs synchronized activity and connectivity in developing human down syndrome cortical excitatory neuron networks | Peter M et al. | β | 2024 | β |
| Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach. | Abukhaled Y et al. | β | 2024 | β |
| Brain circuit pathology in Down syndrome: from neurons to neural networks. | Bartesaghi R | β | 2023 | β |
| Enhancing sleep after training improves memory in down syndrome model mice. | Pittaras E et al. | β | 2022 | β |
| Neurodevelopment in Down syndrome: Concordance in humans and models. | Klein JA et al. | β | 2022 | β |
| Altered cell and RNA isoform diversity in aging Down syndrome brains. | Palmer CR et al. | β | 2021 | β |
| Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome. | Brault V et al. | β | 2021 | β |
| <i>Dyrk1a</i> from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome. | Atas-Ozcan H et al. | β | 2021 | β |
| Kir Channel Molecular Physiology, Pharmacology, and Therapeutic Implications. | Cui M et al. | β | 2021 | β |
| Long-term voluntary running modifies the levels of proteins of the excitatory/inhibitory system and reduces reactive astrogliosis in the brain of Ts65Dn mouse model for Down syndrome. | Kida E et al. | β | 2021 | β |
| Physical Exercise Modulates Brain Physiology Through a Network of Long- and Short-Range Cellular Interactions. | Consorti A et al. | β | 2021 | β |
| Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease. | Alldred MJ et al. | β | 2021 | β |
| Signalling pathways contributing to learning and memory deficits in the Ts65Dn mouse model of Down syndrome. | Freeburn A et al. | β | 2021 | β |
| Structure of cell-cell adhesion mediated by the Down syndrome cell adhesion molecule. | Guo L et al. | β | 2021 | β |
| Plasticity of Synaptic Transmission in Human Stem Cell-Derived Neural Networks. | Dong Y et al. | β | 2020 | β |
| Suprachiasmatic lesions restore object recognition in down syndrome model mice. | Chuluun B et al. | β | 2020 | β |
| A third copy of the Down syndrome cell adhesion molecule (Dscam) causes synaptic and locomotor dysfunction in Drosophila. | Lowe SA et al. | β | 2018 | β |
| CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation. | Alldred MJ et al. | β | 2018 | β |
| Decreasing the Expression of GABA<sub>A</sub> Ξ±5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome. | Vidal V et al. | β | 2018 | β |
| GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome. | Zorrilla de San Martin J et al. | β | 2018 | β |
| Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome. | Scott-McKean JJ et al. | β | 2018 | β |
| RCAN1 Knockdown Reverts Defects in the Number of Calcium-Induced Exocytotic Events in a Cellular Model of Down Syndrome. | VΓ‘squez-Navarrete J et al. | β | 2018 | β |
| A KCNJ6 gene polymorphism modulates theta oscillations during reward processing. | Kamarajan C et al. | β | 2017 | β |
| Increased Sparsity of Hippocampal CA1 Neuronal Ensembles in a Mouse Model of Down Syndrome Assayed by Arc Expression. | Smith-Hicks CL et al. | β | 2017 | β |
| Local translation of the Down syndrome cell adhesion molecule (DSCAM) mRNA in the vertebrate central nervous system. | Montesinos ML | β | 2017 | β |
| Neural plasticity and network remodeling: From concepts to pathology. | Cohen EJ et al. | β | 2017 | β |
| Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome. | RoncacΓ© V et al. | β | 2017 | β |
| Short-term treatment with flumazenil restores long-term object memory in a mouse model of Down syndrome. | Colas D et al. | β | 2017 | β |
| The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome. | Contestabile A et al. | β | 2017 | β |
| Alterations of functional properties of hippocampal networks following repetitive closed-head injury. | Logue OC et al. | β | 2016 | β |
| Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination. | Olmos-Serrano JL et al. | β | 2016 | β |
| DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome. | Duchon A et al. | β | 2016 | β |
| GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App. | Mojabi FS et al. | β | 2016 | β |
| Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis. | LΓ³pez-Hidalgo R et al. | β | 2016 | β |
| Improving Memory and Cognition in Individuals with Down Syndrome. | Rafii MS | β | 2016 | β |
| Neural plasticity and behavior - sixty years of conceptual advances. | Sweatt JD | β | 2016 | β |
| Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome. | Marland JR et al. | β | 2016 | β |
| Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students. | Lepeta K et al. | β | 2016 | β |
| Altered distribution of hippocampal interneurons in the murine Down Syndrome model Ts65Dn. | HernΓ‘ndez-GonzΓ‘lez S et al. | β | 2015 | β |
| Dendritic spine dysgenesis in autism related disorders. | Phillips M et al. | β | 2015 | β |
| Early environmental therapy rescues brain development in a mouse model of Down syndrome. | Begenisic T et al. | β | 2015 | β |
| GIRK Channels: A Potential Link Between Learning and Addiction. | Tipps ME et al. | β | 2015 | β |
| New Perspectives for the Rescue of Cognitive Disability in Down Syndrome. | Bartesaghi R et al. | β | 2015 | β |
| Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. | Gardiner KJ | β | 2015 | β |
| Alcohol modulation of G-protein-gated inwardly rectifying potassium channels: from binding to therapeutics. | Bodhinathan K et al. | β | 2014 | β |
| Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome. | Corrales A et al. | β | 2014 | β |
| Environment and brain plasticity: towards an endogenous pharmacotherapy. | Sale A et al. | β | 2014 | β |
| Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome. | Begenisic T et al. | β | 2014 | β |
| GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. | Rudolph U et al. | β | 2014 | β |
| GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease. | Nava-Mesa MO et al. | β | 2014 | β |
| Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome. | Kaur G et al. | β | 2014 | β |
| Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives. | Deidda G et al. | β | 2014 | β |
| Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome. | Das D et al. | β | 2014 | β |
| Prenatal treatment of Down syndrome: a reality? | Guedj F et al. | β | 2014 | β |
| Treating enhanced GABAergic inhibition in Down syndrome: use of GABA Ξ±5-selective inverse agonists. | MartΓnez-CuΓ© C et al. | β | 2014 | β |
| Amyloid-Ξ² induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse. | Nava-Mesa MO et al. | β | 2013 | β |
| Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. | Altafaj X et al. | β | 2013 | β |
| Prospects for improving brain function in individuals with Down syndrome. | Costa AC et al. | β | 2013 | β |
| Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome. | Colas D et al. | β | 2013 | β |
| Weaker control of the electrical properties of cerebellar granule cells by tonically active GABAA receptors in the Ts65Dn mouse model of Down's syndrome. | Szemes M et al. | β | 2013 | β |
| AKAP150-anchored calcineurin regulates synaptic plasticity by limiting synaptic incorporation of Ca2+-permeable AMPA receptors. | Sanderson JL et al. | β | 2012 | β |
| Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican. | Howell MD et al. | β | 2012 | β |
| Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model. | MΓΆhler H | β | 2012 | β |
| Deregulated mTOR-mediated translation in intellectual disability. | Troca-MarΓn JA et al. | β | 2012 | β |
| Developmentally altered inhibition in Ts65Dn, a mouse model of Down syndrome. | Mitra A et al. | β | 2012 | β |
| Down syndrome: the brain in trisomic mode. | Dierssen M | β | 2012 | β |
| Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome. | Best TK et al. | β | 2012 | β |
| From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome. | Cramer N et al. | β | 2012 | β |
| Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities. | Rueda N et al. | β | 2012 | β |
| Pathways to cognitive deficits in Down syndrome. | Sturgeon X et al. | β | 2012 | β |
| Synaptic pathology of Down syndrome. | Garner CC et al. | β | 2012 | β |
| The in vivo Down syndrome genomic library in mouse. | Herault Y et al. | β | 2012 | β |
| Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice. | Cooper A et al. | β | 2012 | β |
| Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes. | Keck-Wherley J et al. | β | 2011 | β |
| Brain plasticity and disease: a matter of inhibition. | Baroncelli L et al. | β | 2011 | β |
| Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of Ξ²1-adrenergic receptor by xamoterol as a potential cognitive enhancer. | Faizi M et al. | β | 2011 | β |
| Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome. | Begenisic T et al. | β | 2011 | β |
| Environmental enrichment rescues postnatal neurogenesis defect in the male and female Ts65Dn mouse model of Down syndrome. | Chakrabarti L et al. | β | 2011 | β |
| Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine. | Scott-McKean JJ et al. | β | 2011 | β |
| Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome. | Blanchard J et al. | β | 2011 | β |
| Striatum-hippocampus balance: from physiological behavior to interneuronal pathology. | Ghiglieri V et al. | β | 2011 | β |
| The Down syndrome critical region regulates retinogeniculate refinement. | Blank M et al. | β | 2011 | β |
| The use of mouse models to understand and improve cognitive deficits in Down syndrome. | Das I et al. | β | 2011 | β |
| Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of Down syndrome. | Popov VI et al. | β | 2011 | β |
| Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome. | Contestabile A et al. | β | 2010 | β |
| Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome. | Llorens-MartΓn MV et al. | β | 2010 | β |
| Emerging pharmacotherapies for neurodevelopmental disorders. | Wetmore DZ et al. | β | 2010 | β |
| Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. | LΓΌscher C et al. | β | 2010 | β |
| GABAB-GIRK2-mediated signaling in Down syndrome. | Cramer NP et al. | β | 2010 | β |
| Imbalanced pattern completion vs. separation in cognitive disease: network simulations of synaptic pathologies predict a personalized therapeutics strategy. | Hanson JE et al. | β | 2010 | β |
| Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. | Di Filippo M et al. | β | 2010 | β |
| Mouse models of cognitive disabilities in trisomy 21 (Down syndrome). | Roubertoux PL et al. | β | 2010 | β |
| Nurturing brain plasticity: impact of environmental enrichment. | Baroncelli L et al. | β | 2010 | β |
| The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials. | Scott-McKean JJ et al. | β | 2010 | β |
| A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. | Pereira PL et al. | β | 2009 | β |
| Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. | Belichenko PV et al. | β | 2009 | β |
| Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. | Guedj F et al. | β | 2009 | β |
| In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. | Chen Y et al. | β | 2009 | β |
| Normal protein composition of synapses in Ts65Dn mice: a mouse model of Down syndrome. | Fernandez F et al. | β | 2009 | β |
| The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. | Belichenko NP et al. | β | 2009 | β |
| Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome. | Chang Q et al. | β | 2008 | β |
| Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome. | Rueda N et al. | β | 2008 | β |
| Promotion of neuronal plasticity by (-)-epigallocatechin-3-gallate. | Xie W et al. | β | 2008 | β |
| Sleep and EEG features in genetic models of Down syndrome. | Colas D et al. | β | 2008 | β |
| Speeding of miniature excitatory post-synaptic currents in Ts65Dn cultured hippocampal neurons. | Best TK et al. | β | 2008 | β |
| A year of unprecedented progress in Down syndrome basic research. | Reeves RH et al. | β | 2007 | β |
| Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. | Chakrabarti L et al. | β | 2007 | β |
| Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. | Rachidi M et al. | β | 2007 | β |
| Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome. | Fernandez F et al. | β | 2007 | β |
| Over-inhibition: a model for developmental intellectual disability. | Fernandez F et al. | β | 2007 | β |
| Susceptibility to induction of long-term depression is associated with impaired memory in aged Fischer 344 rats. | Foster TC et al. | β | 2007 | β |
| Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. | Belichenko PV et al. | β | 2007 | β |
| The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome. | Hanson JE et al. | β | 2007 | β |
| The power of comparative and developmental studies for mouse models of Down syndrome. | Moore CS et al. | β | 2007 | β |
| Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. | Olson LE et al. | β | 2007 | β |
| Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current. | Best TK et al. | β | 2007 | β |
| Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome. | Harashima C et al. | β | 2006 | β |
| Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome. | Siarey RJ et al. | β | 2006 | β |
| Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome. | MartΓnez-CuΓ© C et al. | β | 2006 | β |
| Down syndrome mouse models are looking up. | Reeves RH | β | 2006 | β |
| DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. | Ahn KJ et al. | β | 2006 | β |
| Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model. | Harashima C et al. | β | 2006 | β |
| Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. | Lorenzi HA et al. | β | 2006 | β |
| Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. | Shukkur EA et al. | β | 2006 | β |
| Mouse models of cognitive disorders in trisomy 21: a review. | SΓ©rΓ©gaza Z et al. | β | 2006 | β |
| Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. | Siarey RJ et al. | β | 2005 | β |
| Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome. | MartΓnez-CuΓ© C et al. | β | 2005 | β |
| Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome. | Costa AC et al. | β | 2005 | β |
| Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. | Hunter CL et al. | β | 2004 | β |
| Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome. | Kurt MA et al. | β | 2004 | β |
| Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. | Kleschevnikov AM et al. | β | 2004 | β |
| Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. | Hunter CL et al. | β | 2004 | β |
| Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory. | Hunter CL et al. | β | 2003 | β |
| Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. | Hunter CL et al. | β | 2003 | β |
| Understanding mental retardation in Down's syndrome using trisomy 16 mouse models. | Galdzicki Z et al. | β | 2003 | β |
| 2001 William Allan Award Address. From Down syndrome to the "human" in "human genetics". | Epstein CJ | β | 2002 | β |
| Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome. | MartΓnez-CuΓ© C et al. | β | 2002 | β |
| Reactivity to object and spatial novelty is normal in older Ts65Dn mice that model Down syndrome and Alzheimer's disease. | Hyde LA et al. | β | 2002 | β |
| Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease. | Kim SH et al. | β | 2001 | β |
| On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models. | Galdzicki Z et al. | β | 2001 | β |
| The role and regulation of adenosine in the central nervous system. | Dunwiddie TV et al. | β | 2001 | β |
| Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. | Hyde LA et al. | β | 2001 | β |